MACKAY SHIELDS LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$42,000
-98.7%
42,000
-98.7%
0.00%
-100.0%
Q2 2021$3,207,000
-88.8%
3,193,000
-88.7%
0.03%
-85.6%
Q1 2021$28,739,000
-5.5%
28,304,000
+0.8%
0.21%
-0.5%
Q4 2020$30,397,000
-10.7%
28,073,000
-14.6%
0.21%
-9.1%
Q3 2020$34,043,000
-6.4%
32,870,000
-0.1%
0.23%
-20.3%
Q2 2020$36,358,000
+8.9%
32,911,000
+0.0%
0.29%
-6.1%
Q1 2020$33,383,000
-11.2%
32,910,000
+0.3%
0.31%
+19.3%
Q4 2019$37,597,000
-42.2%
32,796,000
-42.3%
0.26%
-34.6%
Q3 2019$65,003,000
+61.7%
56,879,000
+67.7%
0.40%
+44.5%
Q2 2019$40,192,000
-7.8%
33,922,000
+5.3%
0.27%
-13.3%
Q1 2019$43,605,000
+25.7%
32,203,000
-0.3%
0.32%
+12.5%
Q4 2018$34,693,000
+2.3%
32,284,000
+0.1%
0.28%
+8.5%
Q3 2018$33,926,000
+16.3%
32,241,000
+8.9%
0.26%
+28.2%
Q2 2018$29,163,000
+20.9%
29,615,000
+21.6%
0.20%
+34.7%
Q1 2018$24,124,000
-6.3%
24,364,000
+0.1%
0.15%
-84.1%
Q4 2017$25,755,000
+0.7%
24,347,000
+0.8%
0.94%
-1.1%
Q3 2017$25,567,000
+4.8%
24,155,000
+5.2%
0.95%
-7.8%
Q2 2017$24,396,000
+35.7%
22,954,000
+23.2%
1.03%
+26.2%
Q1 2017$17,982,000
+73.9%
18,629,000
+82.1%
0.82%
+65.9%
Q4 2016$10,340,000
+8.2%
10,231,000
-0.1%
0.49%
+14.4%
Q3 2016$9,558,000
+31.5%
10,243,0000.0%0.43%
+19.1%
Q2 2016$7,266,000
-22.3%
10,243,0000.0%0.36%
-28.9%
Q1 2016$9,347,000
-19.1%
10,243,0000.0%0.51%
-18.8%
Q4 2015$11,549,00010,243,0000.63%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q1 2018.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders